There have also been promisingefforts to develop ECL biosensors for point-of-care applications,such as lateral flow devices for CRP and IFN-γ detection, asdiscussed in the Electrochemiluminescence-Based Biosensorsfor Tuberculosis Biomarkers section. This evidence concerns the gene CRP and tuberculosis.